Suppr超能文献

一种针对过敏反应中未满足需求的区域性方法。

A regional approach to unmet needs in anaphylaxis.

作者信息

Minale P, Bignardi D, Troise C, Voltolini S, Dignetti P

机构信息

Allergy Unit San Martino Hospital IRCCS (Scientific Institute for Research, Hospitalization and Health Care)-IST, (Institute of Cancer), Genoa, Italy. Largo Rosanna Benzi 10, Genoa, Italy Phone: +39 010 5555 303, +39 347 1644 246 E-mail:

Allergy Unit San Martino Hospital IRCCS (Scientific Institute for Research, Hospitalization and Health Care)-IST, (Institute of Cancer), Genoa, Italy.

出版信息

Eur Ann Allergy Clin Immunol. 2016 May;48(3):88-93.

Abstract

Allergic diseases are under-diagnosed and undertreated despite their wide prevalence, and particularly anaphylaxis is often under-estimated. Evidence-based anaphylaxis guidelines developed by principal allergy organizations agree on increased prevalence of anaphylaxis, especially in patients younger than 18 years (18-27,30): this trend highlights the need for actions on anaphylaxis management and prevention (3,4). Lack of prompt connection between emergency department and allergy unit after discharge, and of a dedicated ICD-9th identification code (18-26), can delay diagnosis and treatment of anaphylaxis (28,29). Also in the experience of our Allergy Unit, patients reach the allergist office after several attacks treated in ED (17), without a previous evaluation and risk assessment. Keeping in mind unmet needs in anaphylaxis (4), we focused on regional approaches to health care delivery. The key point of our project was to establish an active collaboration between allergist clinicians and their counterparts in emergency medicine, with a system of quick filing report of patients discharged from ED with the suspect of anaphylactic reaction, directed to a central allergy unit, acting in a hub and spoke model with the Ligurian allergy network (31). Aim of the project was to improve epidemiological data collection via direct connection among ED and allergy network; moreover, we tried to provide a quick and proper evaluation of all reported patients, identifying, when possible, the agent responsible for anaphylaxis, to provide instructions on how to minimize future exposure; as all individuals at risk for anaphylaxis should carry and know how to self-administer epinephrine, we managed to provide auto injector and proper training when appropriate. A follow up on readmissions was carried out during the study and four months later. In a 20 months observation period (2013/2014), 205 patients were reported: it was possible to reach a diagnosis and risk assessment in 64.3%. Anaphylaxis diagnosis was considered likely if any 1 of 3 criteria is satisfied within minutes to hours: acute onset of illness with involvement of skin, mucosal surface, or both, and at least 1 of the following: respiratory compromise, hypotension, or end-organ dysfunction; 2 or more of the following occur rapidly after exposure to a likely allergen: involvement of skin or mucosal surface, respiratory compromise, hypotension, or persistent gastrointestinal symptoms; hypotension develops after exposure to a known allergen for that patient: age-specific low blood pressure or decreased systolic blood pressure more than 30% compared with baseline. Of 205 patients reported, 132 were classified as severe anaphylaxis; other 73 cases reported were 12 drugs related angioedema (mostly NSAID related), 9 ACEi related angioedema, 3 ereditary C1inh deficiency angioedema, 24 istaminergic idiopatic angioedema, 14 urticaria angioedema, 6 severe asthma, 2 latex reactions; in three patients a proper diagnosis was not achieved due to refuse / impossibility to perform diagnostic workout. Hymenoptera venom and food proved to be the main triggers, followed by drugs. 100% patients at risk of anaphylaxis received self-injectable adrenaline, pertinent education and individual action plan. In the same period, even though short, there were only two readmissions to ED. First result seems to confirm the usefulness of our approach to address some of unmet needs in anaphylaxis management, as recently pointed out by ICON guidelines (4).

摘要

尽管过敏性疾病普遍存在,但仍存在诊断不足和治疗不充分的情况,尤其是过敏反应常常被低估。主要过敏组织制定的循证过敏反应指南一致认为过敏反应的患病率在上升,尤其是在18岁以下的患者中(18 - 27,30):这种趋势凸显了采取过敏反应管理和预防措施的必要性(3,4)。出院后急诊科与过敏科之间缺乏及时联系,以及缺乏专门的ICD - 9识别代码(18 - 26),可能会延迟过敏反应的诊断和治疗(28,29)。在我们过敏科的经验中,患者在急诊科接受几次发作治疗后才到过敏科就诊(17),之前没有进行评估和风险评估。考虑到过敏反应中未满足的需求(4),我们专注于区域医疗服务提供方式。我们项目的关键点是在过敏科临床医生与其急诊医学同行之间建立积极合作,建立一个从急诊科出院的疑似过敏反应患者的快速报备系统,将患者信息导向一个中央过敏科,该过敏科与利古里亚过敏网络以中心辐射模式运作(31)。该项目的目的是通过急诊科与过敏网络之间的直接联系改善流行病学数据收集;此外,我们试图对所有报告的患者进行快速且恰当的评估,尽可能确定导致过敏反应的因素,提供关于如何尽量减少未来接触的指导;由于所有有过敏反应风险的个体都应携带并知道如何自行注射肾上腺素,我们在适当的时候提供了自动注射器并进行了适当培训。在研究期间及四个月后对再次入院情况进行了随访。在20个月的观察期(2013/2014)内,报告了205例患者:其中64.3%的患者得以进行诊断和风险评估。如果在数分钟至数小时内满足以下3条标准中的任何1条,则认为可能诊断为过敏反应:疾病急性发作,累及皮肤、黏膜表面或两者,且至少具备以下1项:呼吸功能不全、低血压或终末器官功能障碍;接触可能的过敏原后迅速出现以下2项或更多情况:皮肤或黏膜表面受累、呼吸功能不全、低血压或持续性胃肠道症状;该患者接触已知过敏原后出现低血压:特定年龄的低血压或收缩压较基线下降超过30%。在报告的205例患者中,132例被归类为严重过敏反应;其他73例报告病例为12例药物相关性血管性水肿(大多与非甾体抗炎药相关)、9例血管紧张素转换酶抑制剂(ACEi)相关性血管性水肿、3例遗传性C1inh缺乏性血管性水肿、24例组胺能特发性血管性水肿、14例荨麻疹血管性水肿、6例严重哮喘、2例乳胶反应;3例患者因拒绝/无法进行诊断检查而未得出确切诊断。膜翅目毒液和食物被证明是主要诱因,其次是药物。100%有过敏反应风险的患者接受了自动注射肾上腺素、相关教育和个人行动计划。在同一时期,尽管时间较短,但只有2例再次入院到急诊科。初步结果似乎证实了我们的方法对于解决过敏反应管理中一些未满足需求的有效性,正如最近ICON指南(4)所指出的那样。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验